Organogenesis Holdings Inc.
ORGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $151 | $101 | $87 | $127 |
| % Growth | 49.7% | 16.2% | -31.6% | – |
| Cost of Goods Sold | $36 | $28 | $24 | $31 |
| Gross Profit | $115 | $73 | $63 | $96 |
| % Margin | 76% | 72.6% | 72.6% | 75.5% |
| R&D Expenses | $13 | $10 | $11 | $12 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $79 | $74 | $73 | $74 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $2 | $7 | $0 |
| Operating Expenses | $94 | $86 | $90 | $85 |
| Operating Income | $21 | -$13 | -$27 | $10 |
| % Margin | 13.7% | -12.5% | -30.9% | 8.1% |
| Other Income/Exp. Net | $1 | $1 | $1 | $0 |
| Pre-Tax Income | $22 | -$12 | -$26 | $10 |
| Tax Expense | $0 | -$2 | -$7 | $3 |
| Net Income | $22 | -$9 | -$19 | $8 |
| % Margin | 14.3% | -9.3% | -21.7% | 6.1% |
| EPS | 0.11 | -0.096 | -0.17 | 0.059 |
| % Growth | 214.3% | 43.4% | -387.2% | – |
| EPS Diluted | 0.11 | -0.096 | -0.17 | 0.058 |
| Weighted Avg Shares Out | 127 | 127 | 126 | 132 |
| Weighted Avg Shares Out Dil | 131 | 127 | 126 | 132 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | -$0 |
| Depreciation & Amortization | $5 | $5 | $4 | $4 |
| EBITDA | $27 | -$6 | -$16 | $15 |
| % Margin | 18.1% | -6.2% | -18.3% | 11.6% |